24小时热门版块排行榜

返回列表

当前只显示满足指定条件的回帖，点击这里查看本话题的所有回帖

lyman829

木虫 (正式写手)

应助: 19 (小学生)
金币: 3505.3
散金: 10
帖子: 437
在线: 1178.7小时
虫号: 470061
注册: 2007-11-29
性别: GG
专业: 合成药物化学

[交流] 【讨论】关于俄罗斯今年上市的一个新药已有7人参与

今年三月份，俄罗斯上市了一个抗流感的新药，商品名是ingavirin,俄语叫Ингавирин，但是居然找不到任何资料有结构报道，不知道各位对于这个药有什么高见，如能找到结构式就最好了

回复此楼

» 猜你喜欢

2026申博已经有0人回复
合成已经有0人回复
药物学论文润色/翻译怎么收费? 已经有249人回复
氨基酸的酰化反应，求大佬解答已经有0人回复
CSC改派-博士生交流访学已经有19人回复
中山大学-第七医院-招科研助理1名（基因设计和克隆、RNA合成）已经有0人回复
中山大学-第七医院-招科研助理1名（基因设计和克隆、RNA合成）已经有1人回复
巴黎萨克雷大学与国家留学基金委合作博士研究生项目-脂质纳米药物/生物材料/多酚递送已经有10人回复
26年申博——已发SCI6篇已经有13人回复

1楼2009-08-12 22:55:24

已阅回复此楼关注TA 给TA发消息送TA红花 TA的回帖

stevesluo

木虫 (正式写手)

应助: 0 (幼儿园)
金币: 1855.3
散金: 5
红花: 1
帖子: 554
在线: 211.9小时
虫号: 695163
注册: 2009-02-02
性别: GG
专业: 药物设计与药物信息

★
小木虫(金币+0.5):给个红包，谢谢回帖交流

Dacarbazine
From Wikipedia, the free encyclopedia
Jump to: navigation, search
Dacarbazine
Systematic (IUPAC) name
5-(3,3-Dimethyl-1-triazenyl)imidazole-4-carboxamide
Identifiers
CAS number 4342-03-4
ATC code L01AX04
PubChem 2942
DrugBank APRD00331
ChemSpider 10481959
Chemical data
Formula C6H10N6O
Mol. mass 182.18
SMILES eMolecules & PubChem
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life 5 hours
Excretion 40% renal (unchanged)
Therapeutic considerations
Pregnancy cat. C

Legal status ℞ Prescription only

Routes IV
Y(what is this?)  (verify)

Dacarbazine (da-KAR-ba-zeen) (brand names DTIC, DTIC-Dome; also known as DIC or Imidazole Carboxamide) is an antineoplastic chemotherapy drug used in the treatment of various cancers, among them malignant melanoma, Hodgkin lymphoma, sarcoma, and islet cell carcinoma of the pancreas. Antineoplastic drugs are drugs which interfere with cell growth and impede the formation of new tissue - in this case, tumor tissue. These drugs are also known as cytotoxic drugs. Dacarbazine belongs to the family of chemicals known as alkylating agents. Dacarbazine is normally administered by injection (a shot) or intravenous infusion (IV) under the immediate supervision of a doctor or nurse.

Contents [hide]
1 History
2 Side effects
3 Common uses
4 Experimental
5 Suppliers
6 See also
7 Sources

[edit] History
See also: History of cancer chemotherapy
Dacarbazine gained FDA approval in May 1975 as DTIC-Dome. The drug was initially marketed by Bayer.

[edit] Side effects
Like many chemotherapy drugs, dacarbazine may have numerous serious side effects, because it interferes with normal cell growth as well as cancer cell growth. Among the most serious possible side effects are birth defects to children conceived or carried during treatment; sterility, possibly permanent; or immune suppression (reduced ability to fight infection or disease). Dacarbazine is considered to be highly emetogenic, and most patients will be pre-medicated with antiemetic drugs like palonosetron or aprepitant. Other significant side effects include headache, fatigue and occasionally diarrhea.

[edit] Common uses
As of mid-2006, dacarbazine is commonly used as a single agent in the treatment of metastatic melanoma, and as part of the ABVD chemotherapy regimen to treat Hodgkin lymphoma, and in the MAID regimen for sarcoma.

[edit] Experimental
Dacarbazine + Oblimersen. In clinical trials for malignant melanoma.

[edit] Suppliers
Bayer continues to supply DTIC-Dome. There are also generic versions of dacarbazine available from APP, Bedford, Mayne Pharma and Sicor (Teva).